ANI Pharmaceuticals to Discuss First Quarter 2025 Financial Results on May 9, 2025, at 8:00 a.m. ET

Core Insights - ANI Pharmaceuticals, Inc. will release its first quarter 2025 financial results on May 9, 2025, before the market opens [1] - A conference call will be hosted by key executives to discuss the results, scheduled for 8:00 a.m. ET on the same day [1] Company Overview - ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics [2] - The company aims for sustainable growth through its Rare Disease business, which includes products in ophthalmology, rheumatology, nephrology, neurology, and pulmonology [2] - ANI also has a Generics business that leverages R&D expertise and U.S.-based manufacturing, along with a Brands business [2]